Heidelberg Pharma AG (ETR:HPHA)

PRESS RELEASE

published on 10/10/2024 at 07:06, 1 year 3 months ago

Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2024
Heidelberg Pharma AG provides insights on its operational progress and financial figures for the first nine months of fiscal year 2024. Development activities, new clinical data, R&D webinars, and guidance updates are highlighted

Financial Figures Clinical Data Heidelberg Pharma AG R&D Webinars Guidance Updates
BRIEF

published on 10/01/2024 at 17:34, 1 year 3 months ago

Heidelberg Pharma Presents Promising Clinical Data for Lead ADC Candidate HDP-101

Clinical Data Heidelberg Pharma HDP-101 Multiple Myeloma ADC
BRIEF

published on 10/01/2024 at 17:34, 1 year 3 months ago

Heidelberg Pharma présente des données cliniques prometteuses pour le candidat ADC phare HDP-101

Heidelberg Pharma HDP-101 Myélome Multiple ADC Données Cliniques
PRESS RELEASE

published on 10/01/2024 at 17:29, 1 year 3 months ago

Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient
Heidelberg Pharma presents new clinical data on lead ADC candidate HDP-101 at IMS 2024, showing complete remission in one patient. Company developing innovative ADCs for cancer treatment

Clinical Data Heidelberg Pharma ADC IMS 2024 Complete Remission
BRIEF

published on 10/01/2024 at 15:32, 1 year 3 months ago

Heidelberg Pharma AG Announces Updated Financial Guidance

Financial Year 2024 Heidelberg Pharma Operating Expenses Updated Guidance Cash Requirements
BRIEF

published on 10/01/2024 at 15:32, 1 year 3 months ago

Heidelberg Pharma AG annonce une mise à jour de ses prévisions financières

Heidelberg Pharma Orientations Mises À Jour Dépenses D'exploitation Exercice Financier 2024 Besoins En Liquidités
PRESS RELEASE

published on 10/01/2024 at 15:27, 1 year 3 months ago

EQS-Adhoc: Heidelberg Pharma AG Announces Updated Guidance
Heidelberg Pharma AG adjusts its 2024 guidance, expecting sales and other income between EUR 10.0 - 12.0 million and operating expenses between EUR 30.0 - 33.0 million. The company anticipates secured financing until mid-2025

Financial Year Heidelberg Pharma AG Operating Expenses Updated Guidance Secured Financing
BRIEF

published on 09/23/2024 at 13:10, 1 year 4 months ago

Heidelberg Pharma to Present New Clinical Data on HDP-101 at IMS 2024

Clinical Data Heidelberg Pharma HDP-101 Multiple Myeloma IMS 2024
BRIEF

published on 09/23/2024 at 13:10, 1 year 4 months ago

Heidelberg Pharma présentera de nouvelles données cliniques sur HDP-101 à l'IMS 2024

Heidelberg Pharma HDP-101 Myélome Multiple Données Cliniques IMS 2024
PRESS RELEASE

published on 09/23/2024 at 13:05, 1 year 4 months ago

Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2024
Heidelberg Pharma announces new clinical data on lead ATAC candidate HDP-101 to be presented at International Myeloma Society Annual Meeting 2024

Clinical Data Heidelberg Pharma HDP-101 ATAC Candidate Myeloma Society

Published on 01/31/2026 at 03:15, 1 day 8 hours ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 1 day 9 hours ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 1 day 9 hours ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 1 day 11 hours ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 1 day 12 hours ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 01/31/2026 at 15:54, 19 hours 25 minutes ago

EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 22 hours 54 minutes ago

JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 8 hours ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 1 day 13 hours ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 1 day 15 hours ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026

View all EQS

Published on 01/30/2026 at 18:40, 1 day 16 hours ago

ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 18:01, 1 day 17 hours ago

Emova Group - Résultats annuels 2024/25
Published on 01/30/2026 at 17:45, 1 day 17 hours ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 1 day 17 hours ago

Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 2 days 2 hours ago

Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés

View all LES ECHOS COMFI WIRE

News